{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:25:09Z","timestamp":1783441509409,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004106","name":"East China Normal University","doi-asserted-by":"publisher","award":["m20190229"],"award-info":[{"award-number":["m20190229"]}],"id":[{"id":"10.13039\/501100004106","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2024CXJQ01"],"award-info":[{"award-number":["2024CXJQ01"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3402000"],"award-info":[{"award-number":["2023YFC3402000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173099"],"award-info":[{"award-number":["82173099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430092"],"award-info":[{"award-number":["82430092"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270960"],"award-info":[{"award-number":["32270960"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","award":["IIT20210001C-R1"],"award-info":[{"award-number":["IIT20210001C-R1"]}],"id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["24QA2707300"],"award-info":[{"award-number":["24QA2707300"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24J22801200"],"award-info":[{"award-number":["24J22801200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23141903300"],"award-info":[{"award-number":["23141903300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23141901800"],"award-info":[{"award-number":["23141901800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ymthe.2025.01.036","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T03:03:49Z","timestamp":1737774229000},"page":"2789-2800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["GITRL enhances cytotoxicity and persistence of CAR-T cells in cancer therapy"],"prefix":"10.1016","volume":"33","author":[{"given":"Binghe","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuntian","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3328-3425","authenticated-orcid":false,"given":"Juliang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.01.036_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2019.12.047","article-title":"Current challenges and emerging opportunities of CAR-T cell therapies","volume":"319","author":"Abreu","year":"2020","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.01.036_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nm.4441","article-title":"CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy","volume":"24","author":"Fry","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.01.036_bib3","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.01.036_bib4","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.01.036_bib5","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2010-04-281931","article-title":"Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19","volume":"116","author":"Kochenderfer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.01.036_bib6","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.970027","article-title":"Chimeric antigen receptor T cells are vulnerable to immunosuppressive mechanisms present within the tumor microenvironment","volume":"3","author":"Beatty","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2025.01.036_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.smim.2015.11.003","article-title":"Reprogramming the tumor microenvironment to enhance adoptive cellular therapy","volume":"28","author":"Beavis","year":"2016","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.036_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ymthe.2025.01.036_bib9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/14712598.2015.1046430","article-title":"TRUCKs: the fourth generation of CARs","volume":"15","author":"Chmielewski","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2025.01.036_bib10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.15252\/emmm.201607485","article-title":"Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts","volume":"9","author":"Hartmann","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.01.036_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41571-021-00530-z","article-title":"A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains","volume":"18","author":"Cappell","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2025.01.036_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1054-1","article-title":"CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape","volume":"568","author":"Hamieh","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.01.036_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","article-title":"Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells","volume":"28","author":"Zhao","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.01.036_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96976","article-title":"Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation","volume":"3","author":"Guedan","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2025.01.036_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrd4597","article-title":"The pharmacology of second-generation chimeric antigen receptors","volume":"14","author":"van der Stegen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.01.036_bib16","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1073\/pnas.94.12.6216","article-title":"A new member of the tumor necrosis factor\/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis","volume":"94","author":"Nocentini","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.01.036_bib17","article-title":"Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation","volume":"2010","author":"Placke","year":"2010","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.036_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-065X.2011.01063.x","article-title":"T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy","volume":"244","author":"Snell","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ymthe.2025.01.036_bib19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm.3922","article-title":"Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells","volume":"21","author":"Kim","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.01.036_bib20","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1038\/s41467-021-22885-8","article-title":"Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas","volume":"12","author":"Amoozgar","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.01.036_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s43018-022-00334-9","article-title":"An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy","volume":"3","author":"Chan","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2025.01.036_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41591-019-0420-8","article-title":"Rational design of anti-GITR-based combination immunotherapy","volume":"25","author":"Zappasodi","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.01.036_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41577-020-0396-0","article-title":"IL-9-producing T cells: potential players in allergy and cancer","volume":"21","author":"Angkasekwinai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.036_bib24","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1038\/ncomms9266","article-title":"GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation","volume":"6","author":"Xiao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.01.036_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.01.036_bib26","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1172\/JCI24480","article-title":"Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells","volume":"115","author":"Gattinoni","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.01.036_bib27","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1172\/JCI65459","article-title":"Th9 cells promote antitumor immune responses in vivo","volume":"122","author":"Lu","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.01.036_bib28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/ni.3252","article-title":"The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells","volume":"16","author":"Nakatsukasa","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.036_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1248327","article-title":"Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients","volume":"5","author":"Nonomura","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2025.01.036_bib30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2856","article-title":"Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.01.036_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00281-016-0599-4","article-title":"T(H)9 cells in anti-tumor immunity","volume":"39","author":"Rivera Vargas","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ymthe.2025.01.036_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1100\/tsw.2007.106","article-title":"GITR-GITRL system, a novel player in shock and inflammation","volume":"7","author":"Krausz","year":"2007","journal-title":"ScientificWorldJournal."},{"key":"10.1016\/j.ymthe.2025.01.036_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.036_bib34","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.4049\/jimmunol.173.8.5008","article-title":"Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells","volume":"173","author":"Stephens","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.036_bib35","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1038\/s41467-020-19672-2","article-title":"Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.01.036_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ni.1846","article-title":"Regulation of IL-9 expression by IL-25 signaling","volume":"11","author":"Angkasekwinai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.01.036_bib37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.immuni.2012.01.020","article-title":"Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells","volume":"36","author":"Elyaman","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.01.036_bib38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.it.2011.01.006","article-title":"Regulating Il9 transcription in T helper cells","volume":"32","author":"Perumal","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2025.01.036_bib39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.immuni.2013.01.007","article-title":"Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP","volume":"38","author":"Yao","year":"2013","journal-title":"Immunity"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625000401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625000401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:04:41Z","timestamp":1780535081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625000401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1525001625000401"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.036","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GITRL enhances cytotoxicity and persistence of CAR-T cells in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}